Biohit Oyj B (BIOBV)

Helsinki
Currency in EUR
2.970
-0.160(-5.11%)
Real-time Data
BIOBV Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
2.9503.220
52 wk Range
1.8004.350
Key Statistics
Edit
Prev. Close
3.13
Open
3.13
Day's Range
2.95-3.22
52 wk Range
1.8-4.35
Volume
48.37K
Average Vol. (3m)
26.98K
1-Year Change
65.17%
Book Value / Share
0.71
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BIOBV Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
3.200
Upside
+7.74%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Biohit Oyj B Company Profile

Biohit Oyj, a biotechnology company, manufactures and sells bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry worldwide. The company’s diagnostic tests product includes the GastroPanel Unified test panel for stomach health check; GastroPanel Four-in-One stomach test; GastroSoft software application to assist clinicians and general practitioner; Biohit Active B12, a test for measuring the levels of active vitamin B12; BIOHIT Total 25OH Vitamin D, a test for determination of vitamin D status; and Biohit Calprotectin test for measuring human calprotectin. It also offers GastroPanel quick test NT, a quantitative immunochromatographic test for the detection of Helicobacter pylori (H. Pylori) and atrophic gastritis; BIOHIT Celiac Quick test for diagnosis of celiac disease; Biohit ColonView Quick test, a test for detection of fecal occult blood; Biohit Helicobacter Pylori UFT300 and Helicobacter Pylori Quick test methods to detect H. pylori infection; and Lactose Intolerance quick test to support the diagnosis of lactose intolerance in a duodenal biopsy specimen. In addition, the company provides acetaldehyde-binding products, such as Acetium capsules that are intended for persons with a low-acid or anacidic stomach; and Acetium lozenge, which helps in quitting smoking; and monoclonal antibodies for use in the areas of cellular pathology, neurobiology, oncology, and human gastric biomarkers research. The company was incorporated in 1988 and is headquartered in Helsinki, Finland.

Employees
47
Market
Finland

Compare BIOBV to Peers and Sector

Metrics to compare
BIOBV
Peers
Sector
Relationship
P/E Ratio
28.8x−2.9x−0.6x
PEG Ratio
0.530.000.00
Price / Book
4.4x2.0x2.6x
Price / LTM Sales
3.4x2.4x3.1x
Upside (Analyst Target)
−0.9%18.2%50.2%
Fair Value Upside
Unlock3.8%7.5%Unlock

Analyst Ratings

0 Buy
0 Hold
1 Sell
Ratings:
1 analysts
Overall Consensus
Sell

Analysts 12-Month Price Target:

Average 3.200
(+7.74% Upside)

Earnings

Latest Release
Nov 18, 2024
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the Biohit Oyj B (BIOBV) Stock Price Today?

The Biohit Oyj B stock price today is 2.97

What Stock Exchange Does Biohit Oyj B Trade On?

Biohit Oyj B is listed and trades on the Helsinki stock exchange.

What Is the Stock Symbol for Biohit Oyj B?

The stock symbol for Biohit Oyj B is "BIOBV."

What Is the Biohit Oyj B Market Cap?

As of today, Biohit Oyj B market cap is 44.79M.

What is Biohit Oyj B Earnings Per Share?

The Biohit Oyj B EPS is 0.109.

What Is the Next Biohit Oyj B Earnings Date?

Biohit Oyj B will release its next earnings report on Feb 12, 2025.

From a Technical Analysis Perspective, Is BIOBV a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.